ANTAGONISM OF 1-(2,5-DIMETHOXY-4-METHYLPHENYL)-2-AMINOPROPANE STIMULUS WITH A NEWLY IDENTIFIED 5-HT(2-) VERSUS 5-HT(1C)-SELECTIVE ANTAGONIST

被引:51
作者
ISMAIEL, AM
DELOSANGELES, J
TEITLER, M
INGHER, S
GLENNON, RA
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,SCH PHARM,DEPT MED CHEM,RICHMOND,VA 23298
[2] ALBANY MED COLL,DEPT PHARMACOL,ALBANY,NY 12208
关键词
D O I
10.1021/jm00069a010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
DOM [i.e., 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane] is a 5-HT1C/2 serotonin agonist that exerts stimulus control of behavior in animals. In order to determine if the discriminative stimulus effect of DOM is 5-HT1C- or 5-HT2-mediated, it would be informative to conduct tests of stimulus antagonism with a 5-HT1C- or 5-HT2-selective antagonist. To date, no such agents exist. Although the neuroleptic agent spiperone binds at D2 dopamine receptors and 5-HT1A serotonin receptors, (a) it displays about a 1000-fold selectivity for 5-HT2 versus 5-HT1C sites and (b) it has been used as a ''5-HT2-selective'' antagonist. Because spiperone is a behaviorally disruptive agent, it is not suitable for use in drug-discrimination studies. Using the spiperone molecule as a starting point, a limited structure-affinity investigation was conducted in order to identify a suitable antagonist with high affinity and selectivity for 5-HT2 receptors, and yet an antagonist that might lack the disruptive actions of spiperone. Various modifications of the spiperone molecule were examined, but most resulted in decreased 5-HT2 affinity or in loss of selectivity. One compound, 8-[3-(4-fluorophenoxy)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one(26), was shown to bind at 5-HT2 sites with high affinity (K(i) = 2 nM) and >2,000-fold selectivity versus 5-HT1C sites. In tests of stimulus antagonism using rats trained to discriminate 1 mg/kg of DOM from saline vehicle, 26 behaved as a potent antagonist (ED50 = 0.003 mg/kg) and lacked the disruptive effects associated with spiperone. As such, (a) it would appear that the DOM stimulus is primarily a 5-HT2-mediated, and not 5-HT1C-mediated, phenomenon, and (b) compound 26 may find application in other pharmacologic investigations where spiperone may not be a suitable antagonist.
引用
收藏
页码:2519 / 2525
页数:7
相关论文
共 25 条
[1]  
ARCHIBALD JL, 1970, Patent No. 2144080
[2]   SYNTHESIS AND CYTOTOXICITY OF 4-AMINOBUTYROPHENONE HYDROCHLORIDES AND THEIR SUBSTITUTED PYRIMIDINYLHYDRAZONES [J].
CHENG, SS ;
PIANTADO.C ;
IRVIN, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 1966, 9 (06) :945-+
[3]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[4]  
DUNCAN RL, 1979, J MED CHEM, V13, P1
[5]  
ELBERMAWY M, 1992, MED CHEM RES, V2, P88
[6]  
Finney D, 1952, PROBIT ANAL
[7]  
Glennon R A, 1991, NIDA Res Monogr, P25
[8]  
Glennon R. A., 1991, SEROTONIN RECEPTOR S, P19
[9]   SEROTONIN RECEPTORS AND THEIR LIGANDS - A LACK OF SELECTIVE AGENTS [J].
GLENNON, RA ;
DUKAT, M .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (04) :1009-1017
[10]   BINDING OF PHENYLALKYLAMINE DERIVATIVES AT 5-HT1C AND 5-HT2 SEROTONIN RECEPTORS - EVIDENCE FOR A LACK OF SELECTIVITY [J].
GLENNON, RA ;
RAGHUPATHI, R ;
BARTYZEL, P ;
TEITLER, M ;
LEONHARDT, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (04) :734-740